GeneTx Biotherapeutics LLC
https://www.genetxbio.com/
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From GeneTx Biotherapeutics LLC
Ovid Shifts Focus After Angelman Syndrome Drug Disappoints In Phase III
The Phase III clinical trial showed a noticeable placebo effect compared with OV101.
Finance Watch: Joe Jimenez Ventures Into Start-Up World Via Aditum
Former Novartis CEO Jimenez co-founded Aditum with former NIBR president Mark Fishman; they raised $133m and are launching Tempero Bio. Also, Atea, Galecto and SQZ went public along with one more health care SPAC, Royalty Pharma upped its Vertex royalty revenues and Mirati’s FOPO raised $926.3m.
Big Companies are from Mars, Small Companies from Venus
A review of the Phoenix '97 CEO conference shows there's a long way to go in bridging the communication gap between large and small companies.
Company Information
- Industry
- Biotechnology